公司資料
Astria Therapeutics, Inc. 股價、新聞與催化劑
- 股票代碼:
- ATXS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for ATXS.
公司概覽
業務概覽
Astria Therapeutics is a biotechnology company focused on allergic and immunologic diseases, especially hereditary angioedema and related conditions. Its story is built around addressing chronic immune-mediated disorders with focused biologics.
所在地與產業分類
Astria is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology biotechnology.
商業模式特徵
The company depends on clinical progress, regulatory milestones, and the ability to build a durable rare-disease franchise. Investors watch efficacy, safety, and commercial readiness.
生技產業定位
Astria occupies a high-value immunology niche within biotech. The stock is catalyst-sensitive because a narrow set of milestones can materially change the long-term outlook.
未來催化劑
- Astria’s catalysts are navenibart and the hereditary-angioedema program, where the next update can materially affect the story. The company still needs clinical proof.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。